We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHAA.WS
9751
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
$543K ﹤0.01%
+553,871
New +$427K
HYTR icon
9752
CP High Yield Trend ETF
HYTR
$292M
$542K ﹤0.01%
22,319
-8
-0% -$193
BKSY icon
9753
CALL
BlackSky Technology
BKSY
$1.26B
$541K ﹤0.01%
+6,775
New +$541K
RNAC icon
9754
CALL
Cartesian Therapeutics
RNAC
$278M
$541K ﹤0.01%
4,317
-6,033
-58% -$718K
BIOC
9755
PUT
DELISTED
Biocept, Inc.
BIOC
$541K ﹤0.01%
4,303
-1,860
-30% -$252K
BMI icon
9756
PUT
Badger Meter
BMI
$3.79B
$540K ﹤0.01%
5,500
+1,300
+31% +$123K
XLRN
9757
CALL
DELISTED
Acceleron Pharma
XLRN
$540K ﹤0.01%
4,300
-2,800
-39% -$353K
IBMO icon
9758
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$569M
$538K ﹤0.01%
+19,958
New +$538K
NYF icon
9759
iShares New York Muni Bond ETF
NYF
$1.44B
$538K ﹤0.01%
+9,202
New +$536K
ROCC
9760
CALL
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$538K ﹤0.01%
22,800
-25,100
-52% -$458K
AILEW
9761
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$538K ﹤0.01%
+625,200
New +$381K
ASHX
9762
DELISTED
Xtrackers MSCI China A Inclusion Equity ETF
ASHX
$538K ﹤0.01%
17,457
-207
-1% -$6.18K
CSTE icon
9763
PUT
Caesarstone
CSTE
$119M
$537K ﹤0.01%
36,400
-25,000
-41% -$378K
ESPO icon
9764
PUT
VanEck Video Gaming and eSports ETF
ESPO
$255M
$537K ﹤0.01%
7,400
+900
+14% +$63.2K
UMAR icon
9765
Innovator US Equity Ultra Buffer ETF March
UMAR
$195M
$537K ﹤0.01%
18,440
+246
+1% +$7.1K
NPTN
9766
DELISTED
NEOPHOTONICS CORP
NPTN
$537K ﹤0.01%
52,601
-32,299
-38% -$341K
ACWI icon
9767
CALL
iShares MSCI ACWI ETF
ACWI
$33.5B
$536K ﹤0.01%
5,300
-90,900
-94% -$9.06M
PBYI icon
9768
CALL
Puma Biotechnology
PBYI
$455M
$536K ﹤0.01%
58,400
+23,100
+65% +$234K
UFI icon
9769
UNIFI
UFI
$149M
$536K ﹤0.01%
22,013
-33,159
-60% -$885K
BNO icon
9770
United States Brent Oil Fund
BNO
$644M
$535K ﹤0.01%
27,776
-28,398
-51% -$498K
MC icon
9771
PUT
Moelis & Co
MC
$5.07B
$535K ﹤0.01%
9,400
+3,400
+57% +$185K
OPFI icon
9772
CALL
OppFi
OPFI
$598M
$535K ﹤0.01%
+52,400
New +$533K
SOL
9773
PUT
DELISTED
Emeren Group
SOL
$535K ﹤0.01%
58,800
-78,800
-57% -$704K
SPRO icon
9774
CALL
Spero Therapeutics
SPRO
$69.3M
$535K ﹤0.01%
38,300
+7,300
+24% +$102K
SPTM icon
9775
PUT
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
$535K ﹤0.01%
+10,100
New +$523K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.